InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,179.20
(
-0.19%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.79
(
0.38%
)
Bitcoin
61,162.19
(
0.57%
)
Post# of 252390
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ToysInTheAttic post# 92668

Thursday, 03/18/2010 8:26:47 PM

Thursday, March 18, 2010 8:26:47 PM

Post# of 252390

You have since taken it upon yourself to form and post your assertions without any substance regarding why.

Here’s the why: SOMX’s business plan does not compute. Inasmuch as one can buy doxepin 10mg capsules at various venues for about ten cents per day*, why would any managed-care group put Silenor on its reimbursement formulary at a premium price?

IMO, the only Silenor you will see in the marketplace in material volume will be the free samples.

*See, for instance, http://www.drugstore.com/pharmacy/prices/drugprice.asp?ndc=49884021701&trx=1Z5006 .


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up